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REID and LEWIN (1957), in a study of certain enzymes concerned in nucleic
acid catabolism, found that nucleoside phosphorylase and xanthine oxidase were
decreased in liver tumours. No study was made ofribonucleases, which according
to a briefpublished report (Allard, 1955) may be normal or even increased during
carcinogenesis. Liver cytoplasm contains at least two ribonucleases, an " acid "
and an " alkaline " ribonuclease (de Lamirande, Allard, da Costa and Cantero,
1954; Roth, 1954). Both are largely " bound " in particles which must be dis-
rupted before assay if full activity is to be obtained (Pirotte and Desreux, 1952;
de Duve, Pressman, Gianetto, Wattiaux and Appelmans, 1955; Nodes and Reid,
1957, unpublished experiments; Roth, 1957). The supernatant fraction remaining
after centrifugation ofcell particles also contains some alkaline ribonuclease which
is, however, accompanied by an inhibitor (Roth, 1956). Taking such difficulties
into account, an independent investigation has now been made of ribonuclease
levels with histologically verified hepatomas induced in rats by azo-dye feeding.
The main part ofthis paper deals with acid-soluble ribonucleotides, as charac-
terized in normal liver by Hurlbert, Schmitz, Brumm and Potter (1954). These
ribonucleotides (nucleoside 5'-phosphates) are known to be present in liver
tumours (Daoust and Cantero, 1955) and in other tumours (Schmitz, Potter,
Hurlbert and White, 1954; Saukkonen, 1956), but no quantitative study with
liver tumours has hitherto been made.
Data are presented not only for liver tumours, but also for liver tissue
(hyperplastic) distant from the tumours, and for " precancerous " liver tissue
from rats fed azo-dye for periods of38 days orless. Since any abnormalities found
with these tissues may well have little bearing on the development ofmalignancy,
the results are considered only briefly.
EXPERIMENTAL
Animals and tissuefractions.-As in a previous study (Reid and O'Neal, 1956),
the tissue fractions were derived from male rats fed on measured amounts ofa diet
which, for the experimental animals, contained 3'-methyl-4-dimethylaminoazo-
benzene. The carcinogen was withdrawn at least 10 days before autopsy or, in the
case of the " precancerous liver " obtained by 23, 28 or 38 days of dye-feeding,
2, 1 or 4 days before autopsy. (All experiments with " precancerous " liver are
treated as comparable except where the results appeared to depend on the dura-
tion of dye feeding.) No food was given on the day of autopsy. The hepatomas
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were firm nodules, any tissue of necrotic appearance in the centre of the nodule
being rejected. The samples of
"liver distant from tumours
" were essentially
free of nodules on gross inspection.
In the ribonuclease experiments, as in the experiments of Reid and O'Neal
(1956) and Reid and Lewin (1957), the tissue samples were homogenized in 0-25
sucrose solution, and the debris (containing nuclei) obtained by centrifugation
for 10 minutes at 600 g was again homogenized and centrifuged. The combined
supernatants (cytoplasm) were centrifuged for 15 minutes at 10,000 g to sediment
a mitochondrial fraction, which was washed once without removal of the "fluffy
layer ". Further centrifugation, for 90 minutes at 14,500 g, gave a microsomal
fraction and a supernatant fraction. The various fractions were stored frozen
30°) until required for assay. Assays for ribonucleases.-The methods, and the choice of substrates, for assay
of ribonucleases were based on the experiments of Stevens and Reid (1956) and
of Nodes and Reid (1957, unpublished experiments) (cf. de Duve et al., 1955);
all assays were carried out in triplicate. To ensure release of
"bound " activity,
the tissue fractions were diluted with water and then frozen and thawed eight
times. Acid ribonuclease were assayed with yeast RNA (dialysed) as substrate, of
which 1 mg. in 0 4 ml. of 0 1 acetate buffer (pH 5.0) was added to 0 3 ml. of the
tissue dilution. Incubation was carried out at 370 with shaking, for 31 minutes or,
with the blanks, for 1 minute. The reaction was stopped by addition of 0 7 ml.
of cold 10 per cent perchloric acid solution containing 0-25 per cent uranyl acetate.
After centrifuging, 0.5 ml. of the supernatant was diluted to 6 ml. for measure-
ment of the extinction at 260m,u (1 cm. light path). The factor 0-066 was used to
convert the net increase in extinction to the activity of the original tissue sample
in terms of ,tmoles of mononucleotide formed per minute (de Duve et al., 1955).
The reaction was linear with respect to tissue concentration up to an extinction
difference (experimental less blank) of0*8.
In assays for alkaline ribonuclease, the diluted tissue fractions were adjusted
to pH 3*5 with N-HCI, and heated for 10 minutes at 650 so as to destroy the
inhibitor (Nodes and Reid, 1957, unpublished; cf. Roth, 1956) together with acid
ribonuclease. The neutralized fractions were then subjected to 8 freeze-thaws as
in the acid ribonuclease assays. The substrate was rat-liver RNA prepared by the
method of Pain and Butler (1957) or, in a few experiments, by the method of
Kirby (1956); 1-5 mg. in 0-2 ml. of 041 histidine buffer pH 8'0) was added to
0.1 ml. ofthe tissue dilution. Incubation was carried out as for acid ribonuclease,
the reaction being stopped by addition of 0 3 ml. of the perchloric acid reagent.
After diluting 0-25 ml. to 4 ml., the extinction was measured at 260 m,u, and the
factor 0*038 used to convert the extinction increase to activity. Since the reaction
was linear with respect to tissue concentration only up to an extinction difference
of 0*10, any assay in which the difference exceeded this value had to be repeated
with a lower tissue concentration.
Ribonucleotides.-The procedures were those described by Hurlbert et al.
(1954) and by Reid and Stevens (1957), and were followed scrupulously so as to
minimize breakdown of the more labile ribonucleotides. In summary, the rats
were killed by decapitation, and the tissue samples were frozen in liquid nitrogen
within one minute and ground to a powder in the frozen state. After extraction
in the cold with perchloric acid solution, and after removal ofthe KC1O4 precipitate
obtained on neutralization of the extract with KOH, gradient elution chromato-
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graphy was carried out with Dowex 1 resin (formate form). Formic acid was
used initially, followed by formic acid-ammonium formate mixtures; the effluent
was collected in 5 ml. portions (about 300 in each run). Certain peaks which were
known to be heterogeneous were rechromatographed using ammonium formate
at pH 5, after removal of the formic acid by freeze-drying and of ammonium
formate by sublimation below 400 (infra-red lamp) under high vacuum (diffusion
pump).
RESULTS
The values obtained for ribonuclease activities and for ribonucleotide levels
in control rats showed fair reproducibility; however, the effect of any variations
in environment ortechnique have been minimized by comparing eachexperimental
rat with a control studied simultaneously, as in previous investigations (Stevens
and Reid, 1956; Reid and O'Neal, 1956; Reid and Stevens, 1957; Reid and
Lewin, 1957). With alkaline ribonuclease, the few values obtained using as sub-
strate RNA prepared by the method of Kirby (1956) have been corrected to be
comparablewiththose obtained usingRNA prepared according to Pain and Butler
(1957).
TABLE I.-Ribonuclease Levels in Tissue Fractions
The values are calculated as ,umoles mononucleotide liberated per min. per
g. oftissue. The standard error is given after each mean difference; the
number ofdegrees offreedom and the probability that the difference could
be due to chance (if < 10 per cent), are given parenthetically.
Prolonged azo-dye feeding
&- I
Control
rats,
mean
Fraction value
Mitochondrial
Microsomal
Supernatant
Mitochondrial
Microsomal
Supernatant
0-81
0-27
0 34
0-27
0-14
0-58
Experimental rats:
difference from
corresponding controls
Liver distant
Hepatoma from tumours
Acid Ribonuclease*
-0U18 +0-03
+0-078 ±0-102 (4)
(6; P< 10%)
-0 05 +0 07
±0-042 (4) +0-063 (3)
+0 11 +0-17
±0*120 (6) ±0-081 (3)
Alkaline Ribonuclease*
-0 05 -0*01
+0-066 (3) ±0-023 (3)
-0-02 +0-06
±0 037 (4) ±0O045 (2)
+0 09 +0 18
±0093 (5) ±0-130 (2)
Brief azo-dye feeding-~~~
Experimental
rats (i.e. " pre-
Control cancerous "liver):
rats, difference from
mean corresponding
value controls
0-72
0-17
0-30
0-32
0-12
0-27
-0-01
±0-07 (3)
+0-01
±0-032 (3)
+0-11
±0-041 (5)
(5; P<5%)
-0-04
±0-031 (6)
-0-04
±0-012
(6; P<2-5%)
-0-02
±0-087 (5)
* Nuclear fractions were not studied, since unbroken cells were present as well as nuclei. In
other experiments in the Laboratory (Stevens and Reid, 1956; Nodes and Reid, 1957, unpublished),
assays on unfractionated cytoplasm have shown satisfactory recoveries of the cytoplasmic activity
in the mitochondrial, microsomal and supernatant fractions (ca. 93 per cent recovery of acid ribo-
nuclease, 90 per cent recovery of alkaline ribonuclease).
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Ribonucleases.-As is evident from Table I, hepatomas showed no consistent
changes except possibly a decrease (ca. 20 per cent; P < 10 per cent) in mito-
chondrial-fraction acid ribonuclease activity. The values for hepatomas were
particularly variable, for both enzymes, with supernatant fractions; the higher
values were not peculiar to one of the two main histological types encountered
(adenocarcinoma; trabecular hepatoma). With " precancerous " liver there was
an increase (ca. 35 per cent) in the acid-ribonuclease activity of supernatant
fractions, and a decrease (ca. 35 per cent) in the alkaline-ribonuclease activity of
microsomal fractions.
Acid-soluble ribonucleotides.-Fig. 1 shows uridine nucleotide levels expressed
as differences from the levels in controls studied simultaneously. Taking into
account that the values for the controls in these and other experiments did not
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FIG. 1.-Changes in acid-soluble uridine nucleotide levels (density units per g. of tissue; if
a nucleotide peak when dissolved in only 1 ml. had E260 = 1 0, 1 density unit would be
present), in comparison with controls studied simultaneously.
In Fig. 1 and Fig. 2, P23 and P38 denote precancerous liver obtained by 23 and 38 days of
dye feeding respectively (one experiment each), H denotes hepatomas (2 experiments, the
individual values being shown by dots), and D denotes liver distant from tumours. Each
experiment was performed with tissue samples derived from 2 rats. The standard errors,
given to indicate the variability encountered in normal rats not given azo-dye, are based
on the results of 6 control experiments (including experiments from other investigations
in this Laboratory).
The values for uridine mono- and triphosphates were obtained by re-chromatography of
heterogenous peaks, the former of which also contained inosine monophosphate. The
values for uridine diphosphate and its glucuronic acid derivative were obtained by
re-chromatography of a peak which also contained adenosine triphosphate.
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vary widely (as judged by the standard errors in Fig. 1), it appears that with
hepatomas there were increases of the order of 50 per cent (although small in
absolute magnitude) in uridine di- and tri-phosphates, with no change in uridine
monophosphate. On the other hand, there were decreases in uridine diphosphate-
glucose and uridine diphosphate-glucuronic acid. There appeared to be similar
changes in liver distant from tumours, except that uridine diphosphate-glucuronic
acid was increased rather than decreased.
MEAN VALUE 2-6
IN CONTROL SERIES:(±0.28)
17 60
(±0.33) (@084)
9.4
(±o087)
16(3 680 1.5
(±0.80) (±0.59) (±0*32)
D
P23
I--
z
0
z
U.'
z
I
<0
FIG. 2.-Changes in levels (density units per g. oftissue) ofacid-soluble nucleotides other than
uridine nucleotides, in comparison with controls studied simultaneously.
The values for adenosine triphosphate and inosine monophosphate were obtained by
re-chromatography, as indicated in the caption to Fig. 1.
With 23 days of dye feeding there were striking increases (of the order of 100
per cent) in the levels ofuridine nucleotides other than the di- and tri-phosphates;
after 38 days of dye feeding no such increases were observed except with uridine
monophosphate.
Fig. 2 shows the results for adenosine nucleotides and for derivatives of these,
namely triphosphopyridine nucleotide (not consistently separable from guanosine
monophosphate), inosine monophosphate, and " ADX ", the latter including
decomposition products of reduced triphosphopyridine nucleotide (Pressman and
Lange, 1957). It is evident that hepatomas have decreased amounts of " ADX ",
adenosine mono- and di-phosphates and inosine monophosphate, but not of
adenosine triphosphate. The only abnormality found in liver distant from
tumours was a high level of adenosine monophosphate.
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With 23 days of dye feeding there were decreases in " ADX " and adenosine
triphosphate, but an increase in adenosine monophosphate. With 38 days,
decreases were found in adenosine mono- and diphosphates (as with hepatomas)
as well as in adenosine triphosphate.
DISCUSSION
As the present experiments were being completed, there appeared the full
report (Allard, de Lamirande and Cantero, 1957) of the experiments mentioned
by Allard (1955). On re-calculating their results as activity per gramme oforiginal
tissue, to be comparable with those now presented, it appears that administration
of 4-dimethylaminoazobenzene led to increases (more marked in tumours than in
precancerous liver) in the activities of both ribonucleases in the supernatant frac-
tion, whereas the activities of the mitochondrial and microsomal fractions de-
creased. The only consistent changes now found were an increase in supernatant-
fraction acid ribonuclease in precancerous liver, a decrease in microsomal-fraction
alkaline ribonuclease in precancerous liver, and possibly a decrease in mitochon-
drial-fraction acid ribonuclease in hepatomas.
The absence of a consistent rise in supernatant-fraction alkaline ribonuclease
in hepatomas apparently conflicts with the results of Allard et al. (1957), but may
be a reflection of the high variability now encountered, reminiscent of that en-
countered by these authors with transplanted as distinct from primary hepatomas.
It should be noted that a high (although variable) proportion of the cytoplasmic
alkaline-ribonuclease activity was now found in the supernatant fraction, whereas
less than one-fifth was found by Allard et at., perhaps because the effect of the
endogenous inhibitor persisted in the assay. Differences in centrifugation tech-
niques, as well as in other conditions, render comparisons difficult between the
two laboratories, although with the acid enzyme there is in fact good agreement
with regard to the distribution in'the cytoplasm of control rats. In the actual
assays as now performed, not only the inhibitor but also the acid enzyme was
destroyed before assaying the alkaline enzyme; moreover the contribution of the
alkaline enzyme to the observed acid ribonuclease activity was probably less than
in the assays ofAllard et al., because of the lower pH now used (510 as compared
with 5 8). At least it can be concluded that the variability now encountered is not
due to differences in food intake, which was kept the same for control rats as for
experimental rats (all rats being fasted overnight before autopsy).
Deckers-Passau, Maisin and de Duve (1957) performed careful studies on acid
ribonuclease levels (per gramme of liver) in rats fed 4-dimethylaminoazobenzene.
Both 'total' activity (in the whole cytoplasm) and more especially the 'free'
activity (in the supernatant fraction) showed increases, especially at an early
stage of dye-feeding and in the tumours. These changes are considered to reflect
changes in the enzyme-containing particles ('lysosomes ').
In other reports published since the distinction between the two ribonucleases
was recognized (cf. Greenstein and Thompson, 1944; Cantero, Daoust and de
Lamirande, 1950), supernatant fractions were not actually assayed; however,
Schneider, Hogeboom, Shelton and Striebich (1953) found no change in the acid-
ribonuclease activity of mitochondrial fractions but a rise in that of whole homo-
genates, on feeding 3'-methyl-4-dimethylaminoazobenzene (as used in the present
experiments) for 28 days; it is not clear if all " bound " activity was released
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before assay. On administering 2-acetylaminofluorene, Roth (1957) found little
change in acid-ribonuclease activity in mitochondrial fractions but a progressive
decrease in alkaline-ribonuclease activity.
The present findings, in conjunction with those discussed above and with
observations on transplanted hepatomas (Maver and Greco, 1956; Allard et al.,
1957), indicate that only two broad generalizations can be made concerning ribo-
nucleases in hepatomas or precancerous liver-that the levels are not markedly
decreased in the cytoplasm as a whole, and that the acid ribonuclease level in the
supernatant fraction is increased with precancerous liver. Allard et al. have
speculated that " the liver tumor cell preserves the enzymes (e.g. ribonucleases)
which are needed for its life and reproduction but can spare those related to a
specialized function ". It appears likely that the role ofribonucleases is catabolic
rather than anabolic (Nodes and Reid, 1957, unpublished); this function may be
important, but as Reid and Stevens (1958) have pointed out it is uncertain whether
ribonuclease levels actually limit the rate of RNA catabolism in the cell.
The data now obtained for the levels of tissue ribonucleotides (nucleoside 5'-
phosphates and their derivates) have been supplemented by labelling data which
are given in the following paper (Reid, 1958). In the study ofDaoust and Cantero
(1955) there may have been post-mortem breakdown of labile nucleotides, and
moreover the chromatographic methods were less satisfactory than those now
available; nevertheless the present findings accord with their conclusion (from
analyses on normal liver, intestinal mucosa and liver tumours) that, " qualita-
tively, the free mucleotide composition among these tissues is much alike."
However, they found that the tumours lacked three uracil derivatives [possibly
identifiable as uridine diphosphate-acetylglucosamine, -glucose and -glucuronic
acid] and had two additional guanine derivatives. The present findings support
this conclusion in only one respect-that uridine diphosphate-glucuronic acid is
decreased in hepatomas. Other uridine derivatives were normal (e.g. the mono-
phosphate) or increased (the di- and triphosphates). Adenosine compounds,
notably the mono- and diphosphates, showed decreases rather than increases;
but there was no fall in adenosine triphosphate, a compound ofparticular interest
in view of its key role as a source ofhigh-energy phosphate. The present findings
are broadly compatible with the conclusion of Saukkonen (1956) that tumours
have an increased proportion of di- and trinucleotides relative to the correspond-
ing mononucleotides and are deficient in " ADX ". The decrease now found in
" ADX " accords with the findings ofGlock and McLean (1957) that liver tumours
(and liver distant from these) were deficient in the reduced form oftriphosphopy-
ridine nucleotide; they also reported a fall in the oxidized form, in disagreement
with results now obtained.
The changes found after only 23 days ofdye feeding differed from those found
in hepatomas; for example, uridine monophosphate was increased whereas
adenosine triphosphate was decreased. The possibility that the early changes
represent a first step towards the changes found in malignant cells is supported
by the apparently transitional values obtained for 38 days of dye feeding; but
proof of this possibility must await further work.
Interpretation of the diverse changes in levels of uridine nucleotides in rela-
tion to their metabolic functions (cf. Leloir, 1956) will not be attempted here;
but it maybepointed out thatthe decreasedlevelofuridine diphosphate-glucuronic
acid in hepatomas might signify decreased glucuronide synthesis (cf.Levvy, 1956).
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SUMMARY
The levels ofacid ribonuclease and alkaline ribonuclease have been determined
in cell fractions obtained from hepatomas induced by 3'-methyl'4'-dimethyl-
aminoazobenzene, and also in liver distant from the tumours and in " precan-
cerous " liver obtained by short periods of dye feeding. Mitochondrial-fraction
acid ribonuclease was low in most of the hepatomas studied. An increase in
supernatant-fraction acid ribonuclease and a decrease in microsomal-fraction
alkaline ribonuclease were found with " precancerous " liver.
Analyses on whole tissue showed increases in uridine di- and tri- (but not
mono-) phosphates in hepatomas, and decreases in uridine diphosphate-glucose
and -glucuronic acid and in adenosine derivatives other than adenosine tri-
phosphate. Different changes were observed in " precancerous liver "; thus
with 23 days of dye feeding there were increases in uridine nucleotides other than
the di- and triphosphates.
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